https://ezh12signals.com/index.....php/psychosocial-pr
Doing an extensive search regarding the health literature using PubMed/Medline and EMBASE on September 11, 2019, we extracted information on medical effects pertaining to benefits (OS, PFS, and depth of hematologic response [DOHR]) and harms (SPM and unpleasant occasions). 2144 references were identified; three studies had been eligible for inclusion. A total of 1760 clients were within the analysis; 507 patients received bortezomib and 395 received ixazomib maintenance. Control hands ha
Like
Comment
Share
